icenticaftor (QBW251) - Novartis
Icenticaftor: Data from P2 trial (NCT04072887) for COPD in H1 2022 (Novartis) - Feb 2, 2022 - Q4 & FY 2021 Results 
P2 data • Chronic Obstructive Pulmonary Disease
https://www.novartis.com/sites/novartis_com/files/q4-2021-investor-presentation.pdf
 
Feb 2, 2022
 
 
4deea839-8718-4d12-84c2-03241bf87d25.png

68bebbb6-4927-458a-a278-f35503e21729.png